COVID-19 Self-testing Study

Sponsor
Columbia University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05701878
Collaborator
(none)
100
1
2
3.9
25.4

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: SMARTest mobile app for COVID-19 self-testing
N/A

Detailed Description

Rapid diagnostic testing has been shown to be an important tool in controlling the spread of the COVID-19 pandemic by identifying people when they are likely to be most contagious and reducing crowding at testing sites. In addition to employer-mandated testing, rapid antigen tests are becoming increasingly used by individuals. A method to promote frequent self-testing would help break the chain of viral transmission, slow the spread of disease, slow the spread of vaccine-resistant variants, and improve pandemic management.

The ubiquity of smartphones along with their data connectivity capabilities and onboard sensors make them an attractive tool to complement rapid diagnostic tests and an important component of decentralized testing. Smartphone-based tools have shown high acceptability among healthcare workers for the real-time tracking of rapid test results.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will either be given access to the self-testing mobile app or not.Participants will either be given access to the self-testing mobile app or not.
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Field Test of COVID-19 Self-testing With Rapid Antigen Tests
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention (App) Group

Participants in this group will be given access to a COVID-19 self-testing app (SMARTest). Access to the app, given exclusively to this group, will be in addition to the 12 COVID-19 self-test kits participants receive.

Behavioral: SMARTest mobile app for COVID-19 self-testing
The mobile app has self-testing features and information with regard to self-testing and COVID-19.

No Intervention: Control (No App) Group

Participants in this group will not be given access to the COVID-19 self-testing app (SMARTest). Participants will only receive the 12 COVID-19 self-test kits.

Outcome Measures

Primary Outcome Measures

  1. COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire [Baseline]

    COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.

  2. COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire [At study completion (~ 1 month after enrollment)]

    COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • comfortable with communication in English

  • 18 years old or older

  • owns a smartphone running either Android or iOS operating systems

  • willing to download a COVID-19 self testing app

  • is willing to receive and send text messages for the study (and fill out surveys linked from text messages)

  • is willing to self-test themselves with COVID-19 rapid tests

Contacts and Locations

Locations

Site City State Country Postal Code
1 ICAP Harlem Prevention Center New York New York United States 10027

Sponsors and Collaborators

  • Columbia University

Investigators

  • Principal Investigator: Jessica Justman, MD, Columbia University
  • Study Chair: Samuel K. Sia, PhD, Columbia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jessica E Justman, MD, Associate Professor of Medicine, Columbia University
ClinicalTrials.gov Identifier:
NCT05701878
Other Study ID Numbers:
  • AAAU0815
First Posted:
Jan 27, 2023
Last Update Posted:
Jan 27, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Jessica E Justman, MD, Associate Professor of Medicine, Columbia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2023